Dennis A. Ausiello - Jun 22, 2022 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
Director
Signature
/s/ Thomas J. DesRosier, Attorney-in-Fact
Stock symbol
MCRB
Transactions as of
Jun 22, 2022
Transactions value $
$0
Form type
4
Date filed
6/24/2022, 04:31 PM
Previous filing
May 27, 2022
Next filing
Nov 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Option (right to buy) Award $0 +35K $0.00 35K Jun 22, 2022 Common Stock 35K $3.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders.